Unlike generalist CROs, our team is structured around the unique challenges of the tumor microenvironment (TME). We combine cutting-edge immunology insights with industrial-scale platforms to provide end-to-end support—from initial Target Discovery and Validation to complex Preclinical Efficacy Evaluation. Website: https://www.creative-biolabs.com/immuno-oncology